Cutting edge imaging, rapid PCI protocols, and patient centered follow up improving outcomes for acute coronary syndromes.
Cases exceeding the 90th percentile for dose, though infrequent, resulted in greater cumulative exposures for all cath lab ...
The risk of dying over the next decade for STEMI patients who survive the first 90 days after primary PCI is just a few percentage points higher than people in the general population, an observational ...
Please provide your email address to receive an email when new articles are posted on . Long-term follow-up from DANAMI-3-PRIMULTI shows reduction in events after complete revascularization vs.
Testing positive for recreational drugs at the time of admission with acute coronary syndrome was associated with increased risk for major adverse cardiovascular events in the following year, ...
Operators safely shaved a few minutes off heart attack reperfusion times by taking patients straight to culprit lesion percutaneous coronary intervention (PCI) when they arrived at the catheterization ...
India, Jan. 25 -- Concept Medical Inc, a global developer of drug-delivery technologies for cardiovascular interventions, has ...
A new study published in the journal of PloS One showed that although reoperative therapy with evolocumab with rosuvastatin ...
SAN DIEGO, CA — Is informed consent necessary to randomize patients with ST-segment elevation MI (STEMI) into clinical trials? That was the question two experts grappled with this week at the Society ...
Findings have indicated that aspirin and clopidogrel could reduce the occurrence of adverse events in patients with ST-segment elevation myocardial infarction (STEMI); however, the overall effect on ...
The Plainview Hospital has now treated 100 ST-elevation myocardial infarction, or STEMI, patients through its new cardiac catheterization laboratory. The hospital held a celebration on May 12 to ...
McKenzie Health System earned two American Heart Association awards, credited with improving cardiac and stroke care in rural ...